EBC-46: A Revolutionary Natural Cancer Treatment from the Blushwood Tree (BANNED ON INSTAGRAM)

This video was banned on instagram, so since it was a public news broadcast its being shared here for information purposes only.

Text is from https://markbarner.com/ebc-46-a-revolutionary-natural-cancer-treatment-from-the-blushwood-tree/

EBC-46 is a groundbreaking natural compound extracted from the fruit of Australia’s blushwood tree (Hylandia dockrillii). Known for its potent anti-cancer properties, EBC-46 belongs to the class of molecules called epoxytiglianes, which have shown remarkable results in targeting cancer cells with precision. Here’s everything you need to know about this promising natural treatment.

What Makes EBC-46 Effective Against Cancer?
1. Cuts Off Tumor Blood Supply

EBC-46 disrupts the blood vessels that nourish tumors, depriving them of oxygen and essential nutrients. This essentially “starves” the tumor, preventing its growth and leading to its death.
2. Triggers Cancer Cell Death

EBC-46 activates a powerful immune response at the tumor site. It induces apoptosis (programmed cell death) in cancer cells while sparing surrounding healthy tissues.
3. Rapid Action

Unlike many traditional cancer treatments, EBC-46 works rapidly. In animal studies, tumors treated with this molecule have shrunk or disappeared entirely within 48 hours.

Scientific Evidence Supporting EBC-46

EBC-46 has been extensively studied in preclinical trials, with promising results:
• Animal Studies:

Dogs, cats, and horses with skin cancers, melanoma, and other localized tumors experienced significant tumor reduction or elimination after being treated with EBC-46.

• Learn more: ScienceDirect Study on EBC-46 in Animals
• Mechanism of Action:

A study published in Nature Scientific Reports demonstrated how EBC-46 induces vascular disruption and triggers a localized immune response at the tumor site.

• Learn more: Nature Scientific Reports on EBC-46
• Human Trials:

Early-stage human clinical trials are ongoing, with preliminary data showing that EBC-46 could be a safer, more targeted alternative to chemotherapy and radiation.